Labcorp Holdings Inc
LH240.340USD
+10.740+4.68%
收盤 04/29, 16:00（美東）報價延遲15分鐘
20.04B總市值
26.87本益比TTM
關於 Labcorp Holdings Inc 公司
Labcorp Holdings Inc. 提供全面的實驗室服務，幫助醫生、醫院、製藥公司、研究人員和患者做出清晰而自信的決定。該公司通過其無與倫比的診斷和藥物開發能力提供見解並加速改善健康和改善生活。該公司通過兩個部門運營：診斷實驗室 (Dx) 和生物製藥實驗室服務 (BLS)。診斷實驗室部門包括常規測試和專業/深奧測試。Dx 通過患者服務中心、分支機構、快速反應實驗室、初級實驗室和專業實驗室網絡運營。生物製藥實驗室服務部門包括早期開發研究實驗室和中央實驗室服務。該公司專注於四個主要專業測試領域，例如腫瘤學、女性健康、自身免疫性疾病和神經病學。
公司簡介
公司代碼LH
公司名稱Labcorp Holdings Inc
上市日期Apr 24, 1991
成立日期2024
CEOMr. Adam H. Schechter
員工數量70000
證券類型Ordinary Share
年結日Apr 24
公司地址358 S Main St
城市BURLINGTON
上市交易所NYSE Consolidated
國家United States of America
郵編27215
電話13362291127
網址https://www.labcorp.com/
公司代碼LH
上市日期Apr 24, 1991
成立日期2024
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Adam H. Schechter
Mr. Adam H. Schechter
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
105.07K
+19.15%
Dr. Brian J. Caveney, M.D., J.D.
Dr. Brian J. Caveney, M.D., J.D.
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
32.07K
+10.11%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Executive Vice President - Special Advisor, Strategy
Executive Vice President - Special Advisor, Strategy
22.53K
+9.59%
Ms. Kerrii B. Anderson, CPA
Ms. Kerrii B. Anderson, CPA
Independent Director
Independent Director
13.17K
-5.65%
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Independent Director
Independent Director
12.89K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Lead Independent Director
Lead Independent Director
12.84K
--
Ms. Richelle P. Parham
Ms. Richelle P. Parham
Independent Director
Independent Director
9.48K
--
Ms. Amy B. Summy
Ms. Amy B. Summy
Executive Vice President, Chief Marketing Officer
Executive Vice President, Chief Marketing Officer
5.30K
+16.66%
Mr. Mark S. Schroeder
Mr. Mark S. Schroeder
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
4.96K
--
Ms. Sandra Dillard van Der Vaart
Ms. Sandra Dillard van Der Vaart
Executive Vice President, Chief Legal Officer, and Corporate Secretary
Executive Vice President, Chief Legal Officer, and Corporate Secretary
3.78K
+109.19%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Adam H. Schechter
Mr. Adam H. Schechter
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
105.07K
+19.15%
Dr. Brian J. Caveney, M.D., J.D.
Dr. Brian J. Caveney, M.D., J.D.
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
32.07K
+10.11%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Executive Vice President - Special Advisor, Strategy
Executive Vice President - Special Advisor, Strategy
22.53K
+9.59%
Ms. Kerrii B. Anderson, CPA
Ms. Kerrii B. Anderson, CPA
Independent Director
Independent Director
13.17K
-5.65%
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Independent Director
Independent Director
12.89K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Lead Independent Director
Lead Independent Director
12.84K
--
收入明細
單位: USD更新時間: 3月12日 週三
單位: USD更新時間: 3月12日 週三
FY2021
FY2020
FY2019
暫無數據
地區USD
名稱
營收
佔比
Northern America
13.09B
81.22%
Europe
2.05B
12.72%
Other Countries
976.40M
6.06%
業務
地區
暫無數據
股東統計
更新時間: 4月27日 週日
更新時間: 4月27日 週日
持股股東
股東類型
持股股東
股東統計
佔比
The Vanguard Group, Inc.
11.49%
BlackRock Institutional Trust Company, N.A.
5.43%
State Street Global Advisors (US)
4.43%
Geode Capital Management, L.L.C.
2.40%
Diamond Hill Capital Management Inc.
2.35%
Other
73.90%
持股股東
股東統計
佔比
The Vanguard Group, Inc.
11.49%
BlackRock Institutional Trust Company, N.A.
5.43%
State Street Global Advisors (US)
4.43%
Geode Capital Management, L.L.C.
2.40%
Diamond Hill Capital Management Inc.
2.35%
Other
73.90%
股東類型
股東統計
佔比
Investment Advisor/Hedge Fund
44.24%
Investment Advisor
41.43%
Hedge Fund
3.71%
Research Firm
2.25%
Pension Fund
1.99%
Bank and Trust
1.53%
Sovereign Wealth Fund
1.31%
Individual Investor
0.40%
Family Office
0.05%
Other
3.09%
機構持股
更新時間: 1月20日 週一
更新時間: 1月20日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q1
1796
81.55M
97.46%
-4.03M
2024Q4
1872
81.10M
96.90%
-5.32M
2024Q3
1856
80.09M
95.55%
-6.82M
2024Q2
1876
81.29M
96.43%
-7.49M
2024Q1
1904
82.39M
97.73%
-8.65M
2023Q4
1947
83.11M
99.02%
-9.76M
2023Q3
1930
84.34M
99.29%
-7.18M
2023Q2
1934
84.05M
94.75%
-3.56M
2023Q1
1940
82.33M
92.89%
-5.93M
2022Q4
1948
82.50M
93.48%
-7.69M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
9.62M
11.49%
+15.33K
+0.16%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
4.55M
5.43%
-7.51K
-0.16%
Dec 31, 2024
State Street Global Advisors (US)
3.70M
4.43%
-23.02K
-0.62%
Dec 31, 2024
Geode Capital Management, L.L.C.
2.00M
2.4%
+39.26K
+2.00%
Dec 31, 2024
Diamond Hill Capital Management Inc.
1.97M
2.35%
-11.59K
-0.59%
Dec 31, 2024
Allspring Global Investments, LLC
1.92M
2.29%
+51.05K
+2.74%
Dec 31, 2024
BlackRock Financial Management, Inc.
1.92M
2.3%
-131.53K
-6.40%
Dec 31, 2024
Select Equity Group, L.P.
1.60M
1.91%
+959.98K
+150.95%
Dec 31, 2024
Citadel Advisors LLC
1.43M
1.71%
+1.30M
+968.69%
Dec 31, 2024
Dimensional Fund Advisors, L.P.
1.36M
1.63%
-4.00K
-0.29%
Dec 31, 2024
查看更多
持股ETF
更新時間: 4月6日 週日
更新時間: 4月6日 週日
機構名稱
佔比
Global X Telemedicine & Digital Health ETF
3.99%
iShares U.S. Healthcare Providers ETF
3.06%
iShares Large Cap Value Active ETF
2.38%
Thrivent Small-Mid Cap ESG ETF
2.01%
SPDR S&P Health Care Services ETF
1.96%
Invesco S&P 500 Equal Weight Health Care ETF
1.73%
SRH US Quality ETF
1.7%
Brandes US Value ETF
1.44%
WisdomTree BioRevolution Fund
1.37%
Schwab Ariel ESG ETF
1.25%
查看更多
Global X Telemedicine & Digital Health ETF
佔比3.99%
iShares U.S. Healthcare Providers ETF
佔比3.06%
iShares Large Cap Value Active ETF
佔比2.38%
Thrivent Small-Mid Cap ESG ETF
佔比2.01%
SPDR S&P Health Care Services ETF
佔比1.96%
Invesco S&P 500 Equal Weight Health Care ETF
佔比1.73%
SRH US Quality ETF
佔比1.7%
Brandes US Value ETF
佔比1.44%
WisdomTree BioRevolution Fund
佔比1.37%
Schwab Ariel ESG ETF
佔比1.25%
分紅派息
近5年累計派現
692.30M
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Jan 09, 2025
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Mar 12, 2025 going ex on Feb 27, 2025
Feb 27, 2025
Mar 12, 2025
Feb 27, 2025
Oct 10, 2024
LH.NB Final Cash Dividend of gross USD 0.72 paid on Dec 13, 2024 going ex on Nov 26, 2024
Nov 26, 2024
Dec 13, 2024
Nov 26, 2024
Jul 25, 2024
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Sep 13, 2024 going ex on Aug 29, 2024
Aug 29, 2024
Sep 13, 2024
Aug 29, 2024
Apr 11, 2024
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Jun 12, 2024 going ex on May 24, 2024
May 28, 2024
Jun 12, 2024
May 24, 2024
Jan 12, 2024
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Mar 13, 2024 going ex on Feb 26, 2024
Feb 27, 2024
Mar 13, 2024
Feb 26, 2024
Oct 12, 2023
LH.NB Final Cash Dividend of gross USD 0.72 paid on Dec 12, 2023 going ex on Nov 07, 2023
Nov 08, 2023
Dec 12, 2023
Nov 07, 2023
Jul 13, 2023
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Sep 08, 2023 going ex on Aug 07, 2023
Aug 08, 2023
Sep 08, 2023
Aug 07, 2023
Apr 06, 2023
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Jun 08, 2023 going ex on May 17, 2023
May 18, 2023
Jun 08, 2023
May 17, 2023
Jan 12, 2023
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Mar 13, 2023 going ex on Feb 22, 2023
Feb 23, 2023
Mar 13, 2023
Feb 22, 2023
Oct 12, 2022
LH.NB Final Cash Dividend of gross USD 0.72 paid on Dec 09, 2022 going ex on Nov 16, 2022
Nov 17, 2022
Dec 09, 2022
Nov 16, 2022
查看更多
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據